Coronavirus India Live Updates: Prime Minister Narendra Modi on Tuesday apprised the floor leaders of both Houses on Covid-19 situation and said that “pandemic should not be a matter of politics and is a matter of concern for entire humanity,” a statement from the Ministry of Parliamentary Affairs stated. PM also stressed the need to properly plan the vaccination drives at the district level based on the advance availability information.
Earlier in the day, the ICMR said that it would be wise to consider reopening primary schools first as children can handle viral infection much better. In the latest national sero survey conducted by ICMR in June-July, one third of the population did not have SARS-CoV-2 antibodies meaning that about 40 crore people still vulnerable to Covid-19 infection. The government further said that 67.6% of India’s population above 6 years have been found to have SARS-CoV-2 antibodies and that 85 per cent of surveyed healthcare workers had antibodies against SARS-CoV-2 while one-tenth of HCWs still unvaccinated.
Meanwhile, four Covid-19 vaccine candidates are at different stages of human trials while one, developed by Genique Life Sciences, is in the advanced pre-clinical stage, Union Science and Technology Minister Jitendra Singh said on Tuesday in a written response to a question in the Rajya Sabha, news agency PTI reported.
He said that Cadila Healthcare Ltd’s DNA-based vaccine candidate is in phase three clinical trial and it has also submitted the interim data for emergency use authorisation. Biological E Ltd’s vaccine candidate is also in phase three clinical trial. Bharat Biotech International Ltd’s Adeno intranasal vaccine candidate is in phase three clinical trial, while Gennova Biopharmaceuticals Ltd’s mRNA-vaccine candidate is in Phase one clinical trial. The Gurgaon-based Genique Life Sciences Pvt Ltd’s vaccine candidate is in the advanced pre-clinical stage, he added.